top of page

PARTNERSHIPS

Please reach out to us to discuss partnering opportunities and how together we can build better cell therapies for patients in need across oncology indications (CAR-T, CAR-NK, TCR-T, γδ T cells, TILs, etc), autoimmune indications, and other cell therapy applications (diabetes, etc).

Waypoint Partnering Areas cell therapies for oncology

CELL THERAPIES FOR ONCOLOGY

Best-in-class against known targets & first-in-class for novel targets or new modalities.

Waypoint Partnering Areas Tregs for autoimmune

TREGS FOR AUTOIMMUNE

Regulatory T cells therapies to treat autoimmune diseases. Optimized for therapeutic efficacy and manufacturing.

Waypoint Partnering Areas target identification and prioritization

TARGET ID & PRIORITIZATION

Human genetics-based target ID and prioritization. Allelic series & deep profiling of in vivo phenotypes.

© 2024 Waypoint Bio

430 E 29th St, New York, NY, 10016

  • LinkedIn
  • White Twitter Icon
bottom of page